Harrow Health, Inc. operates as a pharmaceutical company. The Company specializes in development, production, and sale of medications for treatment of various diseases. Harrow Health operates in the State of California.

Current Report (Form 8-K | Period ending 2025-11-17)

Quarterly Report (Form 10-Q | Period ending 2025-09-30)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Harrow Health (HROW US)

Current Report (Form 8-K | Period ending 2025-11-17)

Quarterly Report (Form 10-Q | Period ending 2025-09-30)

Current Report (Form 8-K | Period ending 2025-08-11)

Current Report (Form 8-K | Period ending 2025-10-06)

Current Report (Amendment) (Form 8-K/A | Period ending 2025-09-24)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)